17 results
8-K
EX-2.1
THRX
Theseus Pharmaceuticals Inc
22 Dec 23
Entry into a Material Definitive Agreement
6:36am
Enforcement Costs
Section 9.02
Existing D&O Policies
Section 7.03(c)
Filed Company SEC Documents
Article IV
Guarantor
Recitals
Guaranty
Recitals
Health Care Submissions … or domestic Governmental Official, employee or health care professional or to any foreign or domestic political parties or campaigns, (iii) violated any
PRE 14A
THRX
Theseus Pharmaceuticals Inc
14 Apr 23
Preliminary proxy
9:00am
company boards, his experience helping shape new technologies, products and markets and his experience leading health care businesses in the United States
S-3
EX-1.2
THRX
Theseus Pharmaceuticals Inc
3 Nov 22
Shelf registration
9:06am
with Health Care Laws. The Company and each Subsidiary are, and at all times have been, in compliance with all Health Care Laws in all material … respects. For purposes of this Agreement, “Health Care Laws” means, to the extent applicable to the Company’s operations: (i) the Federal Food, Drug
10-K
2021 FY
THRX
Theseus Pharmaceuticals Inc
10 Mar 22
Annual report
7:23am
.
The availability and extent of coverage and adequate reimbursement by third-party payors, including government health care programs, private health insurers … or sustain profitability.
In March 2010, the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation
10-Q
4aqwdl4azoc9lhudbff
15 Nov 21
Quarterly report
7:36am
424B4
2s4ddz 9s0wvptu
7 Oct 21
Prospectus supplement with pricing info
5:03pm
S-1/A
EX-1.1
dkr12krqhcp4khyukxc
30 Sep 21
IPO registration (amended)
6:33am
S-1/A
773f rr7oxw0
30 Sep 21
IPO registration (amended)
6:33am
S-1
EX-10.2
fmgre280f i1i8x6
15 Sep 21
IPO registration
4:04pm
S-1
4vroyxr6k8poa
15 Sep 21
IPO registration
4:04pm
DRS/A
9vkye58zeq0c
23 Aug 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.2
ril5es1 x4lrvqy
23 Aug 21
Draft registration statement (amended)
12:00am
DRS
35djnrkto6tzlhyq
20 Jul 21
Draft registration statement
12:00am
D
6klr25v gui8r9
4 Feb 21
$100.1M in equity, sold $95.1M, 16 investors
12:20pm
D/A
buom5q5 ob
4 Feb 21
$22.14M in equity, sold $22.14M, 3 investors
11:27am
D
i6v0wrbrbs52em5ve0
29 Jun 18
$15M in equity, sold $5M, 3 investors
1:30pm
- Prev
- 1
- Next